Osteoarthritis Trial, Recruiting NCT07581470 Sponsor: Poznan University of Medical Sciences Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07581470
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are scheduled for a planned (non-emergency) total hip replacement surgery
  • People whose surgical plan includes a type of nerve-blocking pain relief technique called a PENG block
  • People who fall within a general health rating of low-to-moderate risk for surgery, as assessed by their medical team using a standard scale (ASA physical status I–III)
  • People who are able to understand what the study involves and sign a written consent form
  • People who are able to rate their pain using a simple numbered scale (0–10)

Who may not be able to join:

  • People who have a known allergy or sensitivity to dexamethasone (a type of steroid medication) or any ingredient in the study medication
  • People who have been taking steroid medications regularly, or who have taken them in the 14 days before surgery
  • People who have an active widespread infection or blood infection at the time of the study
  • People who have significantly weakened immune systems, such as from chemotherapy or certain biological treatments
  • People who are pregnant or currently breastfeeding
  • People who have severe difficulties with memory or thinking that would make it hard to reliably report their pain levels
  • People with poorly controlled diabetes — for example, where recent blood sugar control or blood sugar levels on the day are above certain thresholds (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Justyna Marszałek-Buko, MD, Poznan University of Medical Sciences

Phone: +48 (61) 8310122

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poznan University of Medical Sciences
Registry
ClinicalTrials.gov
Start date
8 May 2026
Est. completion
30 June 2027

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Time to First Rescue Analgesia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov